New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of ...
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...
Genomics is partnering with Anthropic to integrate its single cell and spatial biology analysis tools into Claude for Life ...
New plate-based multiplexing unlocks ultra-high-sample and cell-throughput single cell analysis to empower a broad range of studies.
As of February 3, 2023, the average one-year price target for 10x Genomics, Inc. is $50.80. The forecasts range from a low of $25.25 to a high of $68.25. The average price target represents an ...
SAN JOSE, United States, 14 June 2023 – Complete Genomics, Inc., a pioneering genomics company, today unveiled updated mission/vision statement to reflect renewed ambitions in taking on more for a ...
In this piece, we will take a look at the 12 best genomics stocks to buy now. If you want to skip our introduction to the genomics industry and all the latest trends, then take a look at 5 Best ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Contextual Genomics Inc., a leading cancer genomics company, is pleased to announce that it has signed a contribution agreement with the National Research ...
On October 21, 10x Genomics, Inc. and Prognosys Biosciences, Inc. filed a complaint for patent infringement against Illumina, ...
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...
Singular Genomics Systems, Inc. has announced a definitive merger agreement in which an affiliate of Deerfield Management Company will acquire the company for $20.00 per share, a 254% premium over its ...
Native Microbials, Inc., a pioneer in microbial genomics for animal health, and Zesty Paws®, an H&H Group brand and recognized leader and award recipient in the pet supplement industry, announce the ...